APELOA PHARMACEUTI revenue breakdown overview

APELOA PHARMACEUTI revenue for the last year amounted to 11.47 B CNY, the most of which — 7.99 B CNY — came from its highest performing source at the moment, API Intermediates, the year earlier bringing 7.74 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought APELOA PHARMACEUTI 6.55 B CNY, and the year before that — 6.00 B CNY.